8,700 Studies Reviewed. 87.0% Found Biological Effects. The Evidence is Clear.

Gupta V, Srivastava R

Bioeffects Seen

Authors not listed · 2024

Share:

Immune system disruption creates cascading health effects across multiple body systems, not just isolated problems.

Plain English Summary

Summary written for general audiences

Researchers studied how IL-9 immune cells contribute to bone loss in postmenopausal osteoporosis using ovariectomized mice. They found that estrogen loss increases IL-9 production, which accelerates bone-destroying cell activity. Blocking IL-9 improved bone health and maintained gut integrity in the study animals.

Why This Matters

While this study focuses on postmenopausal osteoporosis rather than EMF exposure, it reveals something crucial about immune system dysfunction that parallels what we see in EMF research. The science demonstrates that disrupted immune signaling can cascade into widespread health effects, affecting not just the primary target but connected systems like bone health and gut integrity. This mirrors the multi-system impacts we observe with chronic EMF exposure, where electromagnetic fields disrupt cellular communication pathways and trigger inflammatory responses. What this means for you is that immune system health isn't isolated - when one pathway gets disrupted, whether by hormonal changes or environmental stressors like EMF, the effects can ripple through multiple body systems. The reality is that maintaining immune balance becomes even more critical when we're already facing environmental challenges from our wireless world.

Exposure Information

Specific exposure levels were not quantified in this study.

Cite This Study
Unknown (2024). Gupta V, Srivastava R.
Show BibTeX
@article{gupta_v_srivastava_r_ce3250,
  author = {Unknown},
  title = {Gupta V, Srivastava R},
  year = {2024},
  doi = {10.1093/jbmrpl/ziae120},
  
}

Quick Questions About This Study

IL-9 is an immune system signaling molecule that increases after estrogen loss. This study found it accelerates bone breakdown by enhancing osteoclast cells that destroy bone tissue, contributing to osteoporosis development.
When estrogen levels drop (as in menopause), Th9 and Th17 immune cells dramatically increase their IL-9 production. The researchers found estrogen normally suppresses this inflammatory response, protecting bone health.
Yes, when researchers neutralized IL-9 in ovariectomized mice, bone health improved significantly. The treatment inhibited bone-destroying osteoclasts and inflammatory immune cells while maintaining gut barrier function.
The study found that postmenopausal osteoporotic patients do have increased IL-9-secreting Th9 cells, similar to the mouse model. This suggests IL-9 may play a role in human osteoporosis development.
The research revealed that IL-9 affects a three-way connection between gut health, immune function, and bone metabolism. Blocking IL-9 maintained gut integrity while improving bone health, showing these systems work together.